Translational Development Acquisition TDAC Ratios (2023-2026)

NASDAQ TDAC
$10.83 -0.04 (-0.37%)
As of: Sep 30, 2026 · 3:52 PM EDT
Reported Financials

Translational Development Acquisition Quarterly Ratios

Periods 9 quarters
Latest Jun 2026

Translational Development Acquisition ratios data for the quarter ended Jun 2026. These financial ratios cover 9 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2023 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg. 175.80M177.39M179.08M180.84M182.52M170.36M
Equity AverageEquity Avg. -0.54M-3.08M-5.77M-6.06M-6.27M-6.46M-6.68M-7.25M
Invested CapitalInvested Cap. -0.16M-5.60M-6.28M-6.34M-6.32M-6.58M
Leverage & Solvency
Debt Ratio 171.940.000.000.000.01
Valuation
Price to EarningsP/E 89.8357.7843.8045.2455.27
Enterprise Value 267.57M272.79M274.90M278.64M281.03M305.90M
Market Capitalization 267.78M272.82M274.95M278.67M281.06M305.99M
Return Ratios
Return on Capital Employed [ROCE]ROCE -0.43%-0.51%-0.52%-0.48%-0.78%
Return on Assets [ROA]ROA 1.71%2.66%3.45%3.33%3.20%

Translational Development Acquisition Ratios API

Pull Translational Development Acquisition's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TDAC&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY